SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-23-006673
Filing Date
2023-03-03
Accepted
2023-03-03 16:10:15
Documents
1
Period of Report
2023-03-03

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 4315
  Complete submission text file 0001493152-23-006673.txt   5663
Mailing Address 21925 W. FIELD PARKWAY SUITE 235 DEER PARK IL 60010-7278
Business Address 21925 W. FIELD PARKWAY SUITE 235 DEER PARK IL 60010-7278 (847) 787-7361
Eton Pharmaceuticals, Inc. (Issuer) CIK: 0001710340 (see all company filings)

IRS No.: 371858472 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 5410 TENNESSEE AVE NASHVILLE TN 37209
Business Address
Adams Jennifer McKie (Reporting) CIK: 0001851440 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38738 | Film No.: 23703998